The DOI matches its Crossref record.
Acute Hemodynamic and Clinical Effects of Levosimendan in Patients With Severe Heart Failure
Open accessAbstract
Background—We determined the short-term hemodynamic and clinical effects of levosimendan, a novel calcium-sensitizing agent, in patients with decompensated heart failure. Methods and Results—One hundred forty-six patients with New York Heart Association functional class III or IV heart failure (mean left ventricular ejection fraction 21±1%) who had a pulmonary capillary wedge pressure ≥15 mm Hg and a cardiac index ≤2.5 L · min−1· m−2 were enrolled in a multicenter, double-blind, placebo-controlled study and randomized 2:1 to intravenous infusion of levosimendan or placebo. Drug infusions were uptitrated over 4 hours from an initial infusion rate of 0.1 μg · kg−1· min−1 to a maximum rate of 0.4 μg · kg−1· min−1 and maintained at the maximal tolerated infusion rate for an additional 2 hours. Levosimendan caused dose-dependent increases in stroke volume and cardiac index beginning with the lowest infusion rate and achieving maximal increases in stroke volume and cardiac index of 28% and 39%, respectively. Heart rate increased modestly (8%) at the maximal infusion rate and was not increased at the 2 lowest infusion rates. Levosimendan caused dose-dependent decreases in pulmonary capillary wedge, right atrial, pulmonary arterial, and mean arterial pressures. Levosimendan appeared to improve dyspnea and fatigue, as assessed by the patient and physician, and was not associated with a significant increase in adverse events. Conclusions—Levosimendan caused rapid dose-dependent improvement in hemodynamic function in patients with decompensated heart failure. These hemodynamic effects appeared to be accompanied by symptom improvement and were not associated with a significant increase in the number of adverse events. Levosimendan may be of value in the short-term management of patients with decompensated heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Packer, M., Colucci, W., Fisher, L., Massie, B. M., Teerlink, J. R., Young, J., Padley, R. J., Thakkar, R., Delgado-Herrera, L., Salon, J., et al. (2013) · JACC: Heart Failure · doi:10.1016/j.jchf.2012.12.004 · Cited by 436
Self-citationMcMurray, J. J. V., Teerlink, J. R., Cotter, G., Bourge, R. C., Cleland, J. G. F., Jondeau, G., Krum, H., Metra, M., O’Connor, C. M., Parker, J. D., et al. (2007) · JAMA · doi:10.1001/jama.298.17.2009 · Cited by 360
Low-Cardiac-Output Syndrome After Cardiac Surgery
Lomivorotov, V. V., Efremov, S. M., Kirov, M. Y., Fominskiy, E. V., & Karaskov, A. M. (2017) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2016.05.029 · Cited by 315
Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression
Morelli, A., De Castro, S., Teboul, J.-L., Singer, M., Rocco, M., Conti, G., De Luca, L., Di Angelantonio, E., Orecchioni, A., Pandian, N. G., et al. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2619-z · Cited by 303
Sustained Hemodynamic Effects of Intravenous Levosimendan
Kivikko, M., Lehtonen, L., & Colucci, W. S. (2003) · Circulation · doi:10.1161/01.cir.0000043245.00859.11 · Cited by 258
Self-citation
Metadata
- Authors
- Slawsky, M. T., Colucci, W. S., Gottlieb, S. S., Greenberg, B. H., Haeusslein, E., Hare, J., Hutchins, S., Leier, C. V., LeJemtel, T. H., Loh, E., Nicklas, J., Ogilby, D., Singh, B. N., & Smith, W.
- Venue
- Circulation
- Published
- 2000-10-31
- Volume
- 102
- Issue
- 18
- Pages
- 2222-2227
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2127139759
- Cited by
- 478
- References
- 0
- FWCI
- 15.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acute Hemodynamic and Clinical Effects of Levosimendan in Patients With Severe Heart Failure. https://app.cochat.ai/papers/10.1161/01.cir.102.18.2222
- The paper
- Slawsky, M. T., Colucci, W. S., Gottlieb, S. S., Greenberg, B. H., Haeusslein, E., Hare, J., Hutchins, S., Leier, C. V., LeJemtel, T. H., Loh, E., Nicklas, J., Ogilby, D., Singh, B. N., & Smith, W. (2000). Acute Hemodynamic and Clinical Effects of Levosimendan in Patients With Severe Heart Failure. Circulation. https://doi.org/10.1161/01.cir.102.18.2222
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.